Stay updated on Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T23:29:07.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces the transition to using “Super Intelligence” in place of “Artificial Intelligence” and links to related updates and FAQs.
    Difference
    0.4%
    Check dated 2026-10-25T22:45:25.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T23:13:03.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T23:22:22.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The History page now shows Revision: v3.7.0, replacing the prior v3.6.6. This indicates a metadata or template update to how the record history is displayed, not a change to the study data.
    Difference
    0.1%
    Check dated 2026-09-20T22:34:21.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    A new version adds major sections to the record, including Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Study Description, and Study Status, expanding the publicly visible content of the trial history. Additionally, the entry dated 2026-08-18 was removed.
    Difference
    0.5%
    Check dated 2026-09-13T21:49:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.